The MJ Companies|
Pat Moore joined the MJ team in 2016 and currently serves as a consultant within our Benefits Consulting department. In his role, Pat collaborates with HR managers and corporate officers to develop employee benefit programs that align with their ultimate business goals. Through this effort, he and his team help to identify the primary cost drivers affecting their clients’ benefit plans and work to develop tailored solutions designed to mitigate costs while creating a comprehensive, forward-thinking program.
Pat brings nearly a decade of sales and industry experience to the team. His expertise lies in employee benefits strategy, plan design, and cost containment initiatives. Specializing in identifying and implementing various employee benefits solutions to a wide range of industries, Pat and his team aim to help clients focus beyond benefits to become better, smarter, and more successful.
Related Blogs
2025 Ended with Softest Market Conditions Since 2017 for all Account Sizes & Majority of Lines of Business, The Council’s P/C Market Survey Shows
The MJ CompaniesThe market appeared to move further into the soft part of the insurance market cycle in Q4 2025. Premiums across all account sizes rose ...
Read More
Miles for Miles Helps People With Intellectual and Developmental Disabilities Thrive
Britni ShroutMiles Peck loves school as much for the chance to spend time with his friends as for the classroom experience. He is bracing his ...
Read More
EBSA Updates National Employee Benefit Plan Enforcement Projects for 2026
DeAnn DeckThe Employee Benefits Security Administration (EBSA) announced updates to its national enforcement projects for fiscal year 2026. According to EBSA, these projects highlight areas ...
Read More
The Hard Market Is Shifting—Here’s What That Means for YOU
Adam AdlerFor years, organizations have been told the same thing at renewal: higher costs, fewer options, and little room to negotiate. Now, that message is ...
Read More
Employer Response to Pharma Shifts
Chris AntypasVolatility in the pharmaceutical industry, including the expanding specialty drug pipeline, increased utilization of GLP-1 medications, and persistent supply chain disruptions, are contributing to rising costs ...
Read More
White House Launches TrumpRx, Unveils Drug Prices
DeAnn DeckOn Feb. 5, President Donald Trump announced the launch of TrumpRx.gov, a federally operated website to help individuals buy prescription medications at discounted cash ...
Read More